Form D · Pharmaceuticals

Edison Oncology Holding Corp

Menlo Park, CA · CIK 0001753347

Offering snapshot reported Apr 7, 2021 · SEC filing

Reported sold
$250K
Offering amount: $1.5M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 30, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 7, 2021Initial$250,000No comparison7SEC filing
Oct 12, 2018Initial$632,490No comparison16SEC filing
Sep 18, 2018Initial$125No comparison18SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$25K
Finders' fees
$0
Form D file number
021-394960
Offering terminates 31-Mar/2021
Notes convertible into common stock
Newbridge Securities (NSC) paid 8% placement fee + 2% non-accountable fee. NSC contract terminated by mutual agreement 2-Feb/2021

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NewBridge Securities Corporation104065

Source: Form D, filed Apr 7, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey A Bacha Director, Executive
Sean Martin Director, Executive
Brett Nesland Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3475 Edison Way, Suite R
Menlo Park, CA, 94025